AstraZeneca PLC (AZN)
181.58
-3.38
(-1.83%)
USD |
NYSE |
May 15, 16:00
181.19
-0.39
(-0.21%)
After-Hours: 20:00
AstraZeneca Shareholders Equity (Quarterly) : 47.33B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| GSK Plc | 23.54B |
| Johnson & Johnson | 81.19B |
| Eli Lilly & Co. | 31.20B |
| Merck & Co., Inc. | 45.88B |
| Novo Nordisk A/S | 31.31B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.02B |
| Total Liabilities (Quarterly) | 66.63B |
| Debt to Equity Ratio | 0.7166 |
| Current Ratio | 0.9092 |
| Net Debt Paydown Yield | -0.24% |